Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

Qingqing Chai; Vladimir Jovasevic; Viacheslav Malikov; Yosef Sabo; Scott Morham; Derek Walsh; Mojgan H Naghavi

doi:10.1038/s41467-018-04750-3

Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

Nat Commun. 2018 Jun 5;9(1):2257. doi: 10.1038/s41467-018-04750-3.

Authors

Qingqing Chai¹, Vladimir Jovasevic¹, Viacheslav Malikov¹, Yosef Sabo², Scott Morham³, Derek Walsh¹, Mojgan H Naghavi^{4

5}

Affiliations

¹ Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
² Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY, 10032, USA.
³ MesaGen, LLC, South Salt Lake City, UT, 84115, USA.
⁴ Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA. Mojgan.naghavi@northwestern.edu.
⁵ Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University, New York, NY, 10032, USA. Mojgan.naghavi@northwestern.edu.

Abstract

The original version of this Article contained an error in the Methods section 'Viruses and drugs'. The timing for drug treatment of CHME3 4 × 4 or 293T cells with γ-secretase inhibitor or BACE1 inhibitor was incorrectly given as '1 day prior to infection or transfection' and should have stated '4 or 6 h post transfection or infection, respectively'. This error is now corrected in both the PDF and HTML versions of the Article.

Publication types

Published Erratum

Abstract

Publication types

Grants and funding